EUVIMEDEUVIMED entdecken
Übersichtsarbeit

How Do I Diagnose Fibrolamellar Carcinoma?

Haukur Einarsson, Rondell P Graham

Modern Pathology · 2025-04 · 38 (4) · 100711

DOI: 10.1016/j.modpat.2025.100711 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Modern Pathology, 2025-04. Verfasst von Haukur Einarsson und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibrolamellar carcinoma (FLC) is a unique primary carcinoma of the liver that is characterized by distinct morphologic findings and a recurrent DNAJB1::PRKACA gene fusion. It typically presents in young individuals without underlying liver dysfunction. FLC is difficult to diagnose when based only on morphology, and misdiagnosis is common. Frequent differential diagnoses include conventional hepatocellular carcinoma and intrahepatic cholangiocarcinoma, both of which can show similar morphologic and immunohistochemical features. If based only on molecular analysis, other differential diagnoses have recently emerged, as the DNAJB1::PRKACA fusion has now been reported in cases of intraductal oncocytic papillary neoplasm and intraductal papillary mucinous neoplasm. In this article, we review our diagnostic approach to FLC, which relies on both morphologic and immunohistochemical features, as well as molecular analysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansDiagnosis, DifferentialBiomarkers, TumorCyclic AMP-Dependent Protein Kinase Catalytic SubunitsImmunohistochemistryHSP40 Heat-Shock Proteins

Stichwörter der Autor:innen

DNAJB1::PRKACA fusionPRKACA rearrangementfibrolamellar carcinomahepatocellular carcinoma

Substanzen

Biomarkers, TumorPRKACA protein, humanCyclic AMP-Dependent Protein Kinase Catalytic SubunitsDNAJB1 protein, humanHSP40 Heat-Shock Proteins

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Electronic address: Graham.Rondell@mayo.edu.

Zitieren

APA

Einarsson, H., & Graham, R. P. (2025). How Do I Diagnose Fibrolamellar Carcinoma?. Modern Pathology, 38(4), 100711. https://doi.org/10.1016/j.modpat.2025.100711

Vancouver

Einarsson H, Graham RP. How Do I Diagnose Fibrolamellar Carcinoma?. Modern Pathology. 2025;38(4):100711. doi:10.1016/j.modpat.2025.100711

BibTeX
@article{Einarsson2025,
  author = {Einarsson, Haukur and Graham, Rondell P},
  title = {How Do I Diagnose Fibrolamellar Carcinoma?},
  journal = {Modern Pathology},
  year = {2025},
  volume = {38},
  number = {4},
  pages = {100711},
  doi = {10.1016/j.modpat.2025.100711}
}
Kostenlos starten →